About Biokart
Biokart is a Healthcare company based in Bengaluru (India) founded in 2011. Biokart India offers genomics sequencing, NGS, and bioinformatics services for scientific applications. It operates on a B2B model. Its Indian entity Biokart India Private Limited reported revenue of ₹2.56 Cr. Biokart offers products and services including Sanger Based Services, NGS Based Services, and Bioinformatics Services. Its focus areas include Diagnostics, Viral Sequencing, COVID-19 Analysis and Biotechnology.
Company details
Biokart India is a leading genomics company that leverages advanced technologies for nucleic acid extraction, sequencing, and informatics analysis. They provide tailored services like Sanger and NGS-based solutions, supporting research in microbial genomics and beyond. Based primarily in Bengaluru, India, with branches in Lucknow and Delhi, they collaborate with institutions such as IGIMS for projects like COVID-19 genome sequencing. Their focus is on delivering high-quality, reliable results to clients in the biotechnology sector.
- Headquarters Bengaluru, India
- SectorsHealthcare
- Email••••••••
- Website biokart.com
- Social LinkedIn X Facebook
- Legal Name Biokart India Private Limited
- Date of Incorporation 22 Dec, 2011
- Jurisdiction Bengaluru, Karnataka, India
- Annual Revenue₹2.56 Cr
FY 2024 · -53% YoY
- Net Profit₹15.1 Lakh
FY 2024 · 6% margin
- EBITDA₹22.1 Lakh
FY 2024 · 9% margin
Associated legal entities of Biokart
Biokart operates through Biokart India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biokart India Private Limited CIN U74900KA2011PTC061787 | Active | 22 Dec 2011 | Bengaluru, Karnataka | ₹2.6 Cr | 3 | View details |
Products & Services of Biokart
Biokart offers a comprehensive portfolio of products and services, including Sanger Based Services, NGS Based Services, and Bioinformatics Services.
Provides DNA sequencing for research and analysis purposes.
Offers high-throughput sequencing for microbial and genomic studies.
Delivers computational tools for genomics data interpretation and processing.
Board of directors of Biokart India Private Limited (Biokart)
Biokart India Private Limited is the primary company behind Biokart. The board of Biokart India Private Limited currently have 3 directors; the longest-serving is Vikram Subramanian, appointed in 2011. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vikram Subramanian DIN 03636482 | Director | 22 Dec 2011 | 14 yrs 10 mo | Biokart India Private Limited |
| Madavan Vasudevan DIN 03556084 | Director | 22 Dec 2011 | 14 yrs 10 mo | Biokart India Private Limited |
| Hitesh Goswami Madan DIN 03556183 | Director | 22 Dec 2011 | 14 yrs 10 mo | Biokart India Private Limited |
Financials of Biokart
Figures of Biokart India Private Limited, the primary company behind Biokart, for FY 2024. Revenue was ₹2.56 Cr (-53% year on year). Net profit was ₹15.1 Lakh (6% margin). EBITDA was ₹22.1 Lakh (9% margin). Revenue has grown at a compounded annual rate of +17% over three years and +53% over five years.
- ₹2.56 CrRevenue · FY 2024 · -53% YoY
- ₹15.1 LakhNet profit · 6% margin
- ₹22.1 LakhEBITDA · 9% margin
- ₹1 LakhPaid-up capital
- +17%Revenue CAGR, 3 years
- +53%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Biokart India Private Limited are on its company page.
Detailed financial statements for Biokart
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Biokart
The website of Biokart (biokart.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 1.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biokart
Biokart was founded in 2011.
Biokart is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
The primary company behind Biokart, Biokart India Private Limited, reported revenue of ₹2.56 Cr for FY 2024, down 53% year on year.
Biokart India is a leading genomics company that leverages advanced technologies for nucleic acid extraction, sequencing, and informatics analysis. They provide tailored services like Sanger and NGS-based solutions, supporting research in microbial genomics and beyond. Based primarily in Bengaluru, India, with branches in Lucknow and Delhi, they collaborate with institutions such as IGIMS for projects like COVID-19 genome sequencing. Their focus is on delivering high-quality, reliable results to clients in the biotechnology sector.
Biokart offers Sanger Based Services, NGS Based Services, and Bioinformatics Services.
Biokart operates through Biokart India Private Limited.
The legal entities of Biokart currently have 3 directors, including Vikram Subramanian, Madavan Vasudevan, Hitesh Goswami Madan.